keine Finanzberatung

BAX · Baxter International

Hospital products: IV fluids, infusion systems, surgical supplies

Risiko 6/10 · ELEVATED RISK · medtech turnaround · $25.83 ▲ 1.02%Von KI geschrieben

Stand der Zahlen: · Quellen: öffentliche Markt-Aggregatoren

Kennzahlen

  • Price $25.83
  • Market cap $13.4B
  • P/E (ttm) n/a
  • Div yield 0.15%
  • 52-wk range $15.73 – $30.00
  • Index rank #470 / —

Wichtigste Risiken

  • Turnaround execution while still loss-making (Shareholders) — HIGH
  • Heavy debt load; deleveraging leans on asset sales (Bondholders) — HIGH
  • Hospital pricing pressure on commodity products (Shareholders) — MED
  • Product-quality and recall risk in infusion systems (Patients) — MED

Fazit

A credible self-help story, but still a leveraged, loss-making one — the debt tenders matter more than any single quarter.

Interaktive Analyse öffnen →

Recherche, keine Anlageberatung.

⚠️ Independent research for a video, not financial advice. Figures from public sources/aggregators, can be stale; risk scores are editorial estimates. Verify before relying on any of it.